Summary of Study ST000622
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000454. The data can be accessed directly via it's Project DOI: 10.21228/M8CC9H This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST000622 |
Study Title | Identification and metabolite profiling of chemical activators of lipid accumulation in green algae |
Study Type | GC-MS metabolite profiling of algal lipid activators |
Study Summary | Microalgae are proposed as feedstock organisms useful for producing biofuels and co-products. However, several limitations must be overcome before algae-based production is economically feasible. Among these is the ability to induce lipid accumulation and storage without affecting biomass yield. To overcome this barrier, a chemical genetics approach was employed in which 43,783 compounds were screened against Chlamydomonas reinhardtii and 243 compounds were identified that increase triacylglyceride (TAG) accumulation without terminating growth. Identified compounds were classified by structural similarity and 15 selected for secondary analyses addressing impacts on growth fitness, photosynthetic pigments, and total cellular protein and starch concentrations. TAG accumulation was verified using GC-MS quantification of total fatty acids and targeted TAG and galactolipid (GL) measurements using LC-MRM/MS. These results demonstrated TAG accumulation does not necessarily proceed at the expense of GL. Untargeted metabolite profiling provided important insights into pathway shifts due to 5 different compound treatments and verified the anabolic state of the cells with regard to the oxidative pentose phosphate pathway, Calvin cycle, tricarboxylic acid cycle and amino acid biosynthetic pathways. Metabolite patterns were distinct from nitrogen starvation and other abiotic stresses commonly used to induce oil accumulation in algae. The efficacy of these compounds was also demonstrated in 3 other algal species. These lipid inducing compounds offer a valuable set of tools for delving into the biochemical mechanisms of lipid accumulation in algae and a direct means to improve algal oil content independent of the severe growth limitations associated with nutrient deprivation. |
Institute | University of Nebraska-Lincoln |
Department | Biochemistry |
Laboratory | FATTTLab |
Last Name | Wase |
First Name | Nishikant |
Address | 1901 Beadle Center, Vine Street, 1901 VINE STREET, Lincoln, NE, 68588-0664, USA |
nishikant.wase@gmail.com | |
Phone | 4023109931 |
Submit Date | 2017-06-16 |
Num Groups | 6 |
Publications | 1. Nishikant Wase, Boqiang Tu, James W Allen, Paul N Black, Concetta C DiRusso. Identification and metabolite profiling of chemical activators of lipid accumulation in green algae. Plant Physiology Jun 2017. DOI: 10.1104/pp.17.00433. http://www.plantphysiol.org/content/early/2017/06/26/pp.17.00433; 2. DiRusso, C., & Wase, N. (2016). Compounds for Increasing Lipid Synthesis and Storage. United States. NUtech Ventures (Lincoln, NE, US) http://www.freepatentsonline.com/y2016/0312253.html |
Raw Data Available | Yes |
Raw Data File Type(s) | cdf |
Analysis Type Detail | GC-MS |
Release Date | 2017-10-03 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000454 |
Project DOI: | doi: 10.21228/M8CC9H |
Project Title: | Untargeted metabolomic changes in Chlamydomonas reinhardtii treated with lipid inducing small molecules |
Project Summary: | A study to investigate the effect of small molecule lipid inducing compounds that leads to hyper accumulation of lipids in N replete cells of Chlamydomonas reinhardtii. These compounds were identified through a high throughput screening designed for that purpose. During that screening, we screened 43,783 compounds and identified 367 primary hits. These 367 hits were further retested using a 8-point dilution series (from 0.25 to 30 uM) and verified the activity of 250 compounds that induce the hyper lipid accumulating phenotype in algae. Once the hit compounds were identified and confirmed, we then performed extensive chemoinformatics analysis to look for common scaffolds and identified several common substructures. We then selected 15 top performing compounds from 5 diverse structural groups and tested biochemical parameters such as growth, lipid accumulating capacity, effect on photosynthetic rates, respiration rates, oxygen consumption rates, analysis of different lipid species to quantify and identify fatty acid species using GC-MS. To understand the global changes in the metabolome, 2 structurally different compounds were selected and compared with cells grown without compounds as control for untargeted metabolomics analysis. |
Institute: | University of Nebraska-Lincoln |
Department: | Biochemistry |
Laboratory: | FATTTLab |
Last Name: | Wase |
First Name: | Nishikant |
Address: | 1901 Beadle Center, Vine Street, 1901 VINE STREET, Lincoln, NE, 68588-0664, USA |
Email: | nishikant.wase@gmail.com |
Phone: | 4023109931 |
Funding Source: | NCESR-704, Nebraska Center for Energy Science Research; EPS-1004094 and 1264409, National Science Foundation ; NSF CBET : 1402896, National Science Foundation |
Contributors: | Nishikant Wase, Jiri Adamec, Ron Cerny, Girish Rasineni, Paul N Black, Concetta DiRusso |
Subject:
Subject ID: | SU000645 |
Subject Type: | Photosynthetic organism |
Subject Species: | Chlamydomonas reinhardtii |
Taxonomy ID: | 3055 |
Genotype Strain: | Wild Type |
Species Group: | Microorganism |
Factors:
Subject type: Photosynthetic organism; Subject species: Chlamydomonas reinhardtii (Factor headings shown in green)
mb_sample_id | local_sample_id | Class |
---|---|---|
SA035018 | ContB_1 | Control |
SA035019 | ContA_1 | Control |
SA035020 | ContA_2 | Control |
SA035021 | ContB_2 | Control |
SA035022 | ContA_3 | Control |
SA035023 | ContB_3 | Control |
SA035024 | ContC_3 | Control |
SA035025 | ContC_2 | Control |
SA035026 | ContC_1 | Control |
SA035027 | 461_B_2 | WD10461 |
SA035028 | 461_B_1 | WD10461 |
SA035029 | 461_B_3 | WD10461 |
SA035030 | 461_A_3 | WD10461 |
SA035031 | 461_C_3 | WD10461 |
SA035032 | 461_A_2 | WD10461 |
SA035033 | 461_C_2 | WD10461 |
SA035034 | 461_C_1 | WD10461 |
SA035035 | 461_A_1 | WD10461 |
SA035036 | 784_C_1 | WD10784 |
SA035037 | 784_C_2 | WD10784 |
SA035038 | 784_A_2 | WD10784 |
SA035039 | 784_B_3 | WD10784 |
SA035040 | 784_B_2 | WD10784 |
SA035041 | 784_A_1 | WD10784 |
SA035042 | 784_A_3 | WD10784 |
SA035043 | 784_B_1 | WD10784 |
SA035044 | 784_C_3 | WD10784 |
SA035045 | 067_A_2 | WD20067 |
SA035046 | 067_C_1 | WD20067 |
SA035047 | 067_C_2 | WD20067 |
SA035048 | 067_C_3 | WD20067 |
SA035049 | 067_B_3 | WD20067 |
SA035050 | 067_B_2 | WD20067 |
SA035051 | 067_A_3 | WD20067 |
SA035052 | 067_B_1 | WD20067 |
SA035053 | 067_A_1 | WD20067 |
SA035054 | 542_A_1 | WD20542 |
SA035055 | 542_A_3 | WD20542 |
SA035056 | 542_A_2 | WD20542 |
SA035057 | 542_C_3 | WD20542 |
SA035058 | 542_B_2 | WD20542 |
SA035059 | 542_B_1 | WD20542 |
SA035060 | 542_C_1 | WD20542 |
SA035061 | 542_C_2 | WD20542 |
SA035062 | 542_B_3 | WD20542 |
SA035063 | 030_B_1 | WD30030 |
SA035064 | 030_A_3 | WD30030 |
SA035065 | 030_A_2 | WD30030 |
SA035066 | 030_B_2 | WD30030 |
SA035067 | 030_A_1 | WD30030 |
SA035068 | 030_C_3 | WD30030 |
SA035069 | 030_C_2 | WD30030 |
SA035070 | 030_C_1 | WD30030 |
SA035071 | 030_B_3 | WD30030 |
Showing results 1 to 54 of 54 |
Collection:
Collection ID: | CO000639 |
Collection Summary: | Cells were pre-grown to mid-log phase and treated with 5 selected compounds (final concentration 5 µM) with an initial cell density of 1.0 x 106 cells/mL (100 mL volume; in triplicate) and allowed to grow for 72 h. After 72 h of growth, cells were harvested, media removed and freeze-dried. Accurately measured 50 ± 0.5 mg of freeze dried powder was used for metabolite extraction. Sample powder was pulverized with a single steel ball using TissueLyser LT (Qiagen) at 50 Hz speed for 5 min |
Sample Type: | Algae |
Treatment:
Treatment ID: | TR000659 |
Treatment Summary: | Cells were treated either with compounds (5 uM) final concentration in DMSO or DMSO alone (in case of control). Mid-log phase cells were used as starter culture at a initial inoculum density of 1.0E06 cells/mL in 250 mL flasks with 100 mL of TAP media. Cells were allowed to grow in orbital shaker under constant light for 72 hours. After 72 hours, experiment was terminated and cells were harvested via centrifugation. |
Sample Preparation:
Sampleprep ID: | SP000652 |
Sampleprep Summary: | Harvested cells were flash frozen in liquid N and freeze dried. Accurately measured 50 ± 0.5 mg of freeze dried powder was used for metabolite extraction. Sample powder was pulverized with a single steel ball using TissueLyser LT (Qiagen) at 50 Hz speed for 5 min. One milliliter of extraction buffer containing MeOH:CHCl3:H2O (5:2:2; v/v/v; pre-cooled at -20 °C) was added and vortexed for 5 min. Ribitol (0.2 mg/mL in water; 10 µL) was spiked in the extraction buffer as internal standard in order to identify potential chromatographic errors. The homogenized material was centrifuged at 14000 rpm for 5 min and the supernatant was transferred to new tubes. 400 µL of pure water was added to the supernatant, samples were vortexed and centrifuged at 14,000 rpm for 5 min. The upper polar phase was transferred to new tubes for GC-MS analysis. An aliquot of 300 µL was dried out in vacuum concentrator without heating. To the dried material, 10 µL methoxyamine HCL in 100% pyridine (40 mg/mL) was added and shaken at 30 °C for 90 minutes and subsequently 90 µL of MSTFA 1% TMCS was added for trimethylsilylation of acidic protons and shaken at 37 °C for 30 minutes. The reaction mixture was transferred to GCvials with glass microinserts and closed by crimp caps. GC-MS data acquisition was performed as per previously published report (Wase et al., 2014) |
Combined analysis:
Analysis ID | AN000954 |
---|---|
Analysis type | MS |
Chromatography type | GC |
Chromatography system | Agilent 6890N |
Column | Agilent DB-5MS UI Capillary column |
MS Type | EI |
MS instrument type | Single quadrupole |
MS instrument name | Agilent 5973 |
Ion Mode | POSITIVE |
Units | peak area |
Chromatography:
Chromatography ID: | CH000679 |
Instrument Name: | Agilent 6890N |
Column Name: | Agilent DB-5MS UI Capillary column |
Internal Standard: | Ribitol |
Sample Injection: | 1 uL |
Chromatography Type: | GC |
MS:
MS ID: | MS000849 |
Analysis ID: | AN000954 |
Instrument Name: | Agilent 5973 |
Instrument Type: | Single quadrupole |
MS Type: | EI |
Ion Mode: | POSITIVE |